Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2011 August;66(4) > Minerva Chirurgica 2011 August;66(4):329-39

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,877


eTOC

 

REVIEWS  


Minerva Chirurgica 2011 August;66(4):329-39

language: English

Sleeve resections for the treatment of non-small cell lung cancer

Bölükbas S. 1, Ghezel-Ahmadi D. 1, Kudelin N. 1, Biancosino C. 1, Eberlein M. 2, Schirren J. 1

1 Department of Thoracic Surgery, Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany;
2 Division of Pulmonary, Critical Care and Occupational Medicine, Carver College of Medicine, University of Iowa, Iowa City, USA


PDF  


Parenchyma-sparing sleeve lobectomies were originally developed as a surgical strategy for patients not fit for a pneumonectomy, because of impaired pulmonary function. As promising short- and long-term results were demonstrated, sleeve lobectomy was accepted as an alternative surgical procedure to pneumonectomy. Nowadays, sleeve resections are associated with prolonged long-term survival and better quality of life, compared to pneumonectomy. Therefore, sleeve resections should be performed for centrally located non-small cell lung cancer (NSCLC) whenever technically, anatomically and oncologically possible. In this review, we discuss the current status of sleeve resections in the management of NSCLC.

top of page

Publication History

Cite this article as

Corresponding author e-mail

Dr.Bolukbas@gmx.de